Clinical Trial Update: Lowering Events in Non-proliferative Retinopathy in Scotland [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in Scotland assessing strategies to reduce events in non-proliferative diabetic retinopathy has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Non-proliferative Diabetic Retinopathy

Snippet

Sponsor: University of Oxford | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED | Results posted: 2025-05-14